Nicole Williams was named to the board of directors of Arryx of Chicago while Kenneth Bradley was appointed to the new post of chief operating officer. Williams is executive vice president and chief financial officer of American Pharmaceutical Partners. She is also a member of the board of directors of Orchid BioSciences. Williams holds an MBA from the University of Chicago and a master’s degree in international affairs from the University of Geneva, Switzerland. Bradley had been vice president of operations for Arryx since January 2001. Previously, he founded Phoenician Market Places, a technology development firm.
Bruno Maruzzo was named director of corporate development for Toronto-based ChondroGene. Maruzzo holds a BSc in electrical engineering from the University of Waterloo, and an MSc in biomedical engineering and an MBA from the University of Toronto.
Michael Witt was named as executive director of MichBio, a Michigan biosciences industry association. Prior to joining MichBio, Witt was chief executive officer of Technology Enterprise of Sacramento, Calif., and Flint, Mich., and chief executive officer of vCure.com, a healthcare information and software company in Troy, Mich. Witt holds a pharmacy degree from the University of California, San Francisco School of Pharmacy, and a JD from Case Western Reserve University School of Law.
Edward Scolnick was named to the scientific advisory board of Cambridge, Mass.-based GenPath. Scholnick is president emeritus of Merck Research Labs.
Biotique Systems of Emeryville, Calif., last week named Claudio Schmid as vice president and general manager of the company’s new European office in Basel, Switzerland, and Brad Lomas as general counsel and vice president for business development.
Makoto Ogasawara, treasurer and director for life science of ITX International Holdings of Tokyo, has been appointed CEO of newly founded GeneFrontier of Tokyo, which will distribute NimbleGen microarray systems in Japan.